DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Di Lorenzo G, Carteni G, Autorino R et al.
Phase II study of sorafenib in patients with sunitinib-refractory metastatic renal cell cancer.
J Clin Oncol 2009;
27: 4469-4474
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.